Form 4: Dexcom EVP Sells Shares Under Pre-Arranged 10b5-1 Plan

Dexcom's Executive Vice President and Chief Legal Officer, Michael Jon Brown, sold 500 shares of common stock for $86.03 per share on July 15, 2025, under a pre-arranged 10b5-1 plan.

Summary

• Michael Jon Brown, the Executive Vice President and Chief Legal Officer of Dexcom Inc. (DXCM), reported the sale of company common stock.
• A total of 500 shares of common stock were sold on July 15, 2025.
• The shares were sold at a price of $86.03 per share.
• The transaction was conducted pursuant to a Rule 10b5-1 plan, which Mr. Brown adopted on February 21, 2025, designed for the orderly disposition of shares.
• Following this transaction, Mr. Brown beneficially owns 94,602 shares of Dexcom common stock.
• The beneficially owned shares include 86,490 unvested restricted stock units (RSUs) with various vesting schedules, including grants from March 8, 2022, March 8, 2023, March 8, 2024, and two grants from March 8, 2025, with vesting extending through March 8, 2028.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine Form 4 filing detailing an executive's pre-planned stock sale under a 10b5-1 plan, which is a common practice for orderly disposition of shares and does not inherently signal positive or negative company performance.

Positives

• The sale was executed under a Rule 10b5-1 plan, indicating a pre-scheduled and non-discretionary transaction, which often mitigates concerns about insider selling based on material non-public information.

Negatives

• An executive sold a portion of their company stock holdings.

Risks

• No specific risks are detailed in this Form 4 filing beyond the general implications of insider stock sales, which are mitigated by the use of a 10b5-1 plan.

Future Outlook

NA

Management Comments

• The 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown.

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale of 500 shares by an executive represents a minor disposition of equity, which is pre-planned under a 10b5-1 plan, typically minimizing any negative perception of insider selling.

Key Dates

Recommendation

Keywords

Dexcom, DXCM, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Executive Compensation, Michael Jon Brown, Restricted Stock Units